12 Health Care Stocks Moving In Friday's Intraday Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant price movements during Friday's intraday session. Notable gainers included Athira Pharma, ChromaDex, and Theriva Biologics, while Lexicon Pharmaceuticals and Myriad Genetics were among the biggest losers.
November 01, 2024 | 4:36 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Lexicon Pharmaceuticals' stock fell 35.1% to $1.26, significantly decreasing its market value.
The sharp decline in Lexicon Pharmaceuticals' stock price indicates negative market sentiment or news, likely leading to short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Myriad Genetics' stock decreased by 21.57% to $17.23, affecting its market cap.
The decline in Myriad Genetics' stock price suggests negative investor sentiment or news, likely leading to short-term losses.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 75
POSITIVE IMPACT
Athira Pharma's stock surged by 50.3% to $0.64, significantly increasing its market value.
The substantial increase in Athira Pharma's stock price suggests positive market sentiment or news, likely leading to short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
ChromaDex shares rose 45.55% to $5.08 following the release of its Q3 earnings.
The significant rise in ChromaDex's stock price is likely due to positive Q3 earnings, indicating strong financial performance.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
Theriva Biologics saw a 27.44% increase in its stock price to $1.86.
The rise in Theriva Biologics' stock price suggests positive investor sentiment or news, likely leading to short-term gains.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70